Lyons, France

Jean-François Dubuisson

USPTO Granted Patents = 38 

 

Average Co-Inventor Count = 3.6

ph-index = 16

Forward Citations = 627(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
38 patents (USPTO):Explore Patents

Title: Innovations of Jean-François Dubuisson in Pharmacokinetics

Introduction

Jean-François Dubuisson, an esteemed inventor based in Lyons, France, has made significant contributions to the field of pharmacokinetics. With an impressive portfolio of 26 patents, he has driven advancements that aim to improve therapeutic outcomes through innovative drug formulations.

Latest Patents

Among his latest contributions are the patents for modified release gamma-hydroxybutyrate formulations, which exhibit improved pharmacokinetics. These formulations are designed to enhance dissolution and pharmacokinetic properties, presenting significant therapeutic uses. His work in this area showcases a commitment to developing more effective treatments.

Career Highlights

Dubuisson has a notable career with key roles at Flamel Ireland Limited and Maat Pharma. His experience in these companies has positioned him as a leader in pharmacological innovation, where he has been instrumental in developing groundbreaking drug delivery systems.

Collaborations

Throughout his career, Dubuisson has collaborated with fellow innovators like Claire Mégret and Hervé Guillard. These partnerships have further enriched his research and development efforts, fostering a collaborative environment that cultivates inventive breakthroughs in pharmaceuticals.

Conclusion

In summary, Jean-François Dubuisson stands out as a pioneering inventor in the field of pharmacokinetics. His extensive patent portfolio and collaborative spirit continue to drive innovations that have the potential to transform therapeutic practices, affirming his status as a key figure in pharmaceutical advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…